LMP2A induces the phosphorylation of AKT, activates the PI3K/AKT pathway, and simultaneously inhibits epithelial cell differentiation in EBV-infected cells, and it is suggested that this process occurs via the same mechanism that contributes to the progression of carcinomas and lymphomas associated with EBV. This evidence concerns the gene AKT1 and lymphoma.